Regenerative Medicine in the Cornea

Principles of Regenerative Medicine

Volumn , Issue , 2011, Pages 911-924

  Griffith, May ^a   Fagerholm, Per ^a   Lagali, Neil ^a   Latorre, Malcolm A ^a   Hackett, Joanne ^a   Sheardown, Heather ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882499673     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381422-7.10049-5     Document Type: Chapter

References (91)

1. Ament J.D., Spur-Michaud S.J., Dohlman C.H., Gipson I.K. The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea 2009, 28:808-1131.
2. Amis E., Carriere C., Ferry J., Veis A. Effect of pH on collagen flexibility determined from dilute solution viscoelastic measurements. Int. J. Biol. Macromol. 1985, 7:130-134.
3. Ardjomand N., Hau S., McAlister J.C., Bunce C., Galaretta D., Tuft S.J., et al. Quality of vision and graft thickness in deep anterior lamellar and penetrating corneal allografts. Am. J. Ophthalmol. 2007, 143:228-235.
4. Aucoin L., Griffith C.M., Pleizier G., Deslandes Y., Sheardown H. Interactions of corneal epithelial cells and surfaces modified with cell adhesion peptide combinations. J. Biomater. Sci. Polym. Ed. 2002, 13:447-462.
5. Auger F.A., Remy-Zolghadri M., Grenier G., Germain L. A truly new approach for tissue engineering: the LOEX self-assembly technique. Ernst Schering Res. Found. Workshop, 2002, 73-88.
6. Bareiss B., Ghorbani M., Li F., Blake J.A., Scaiano J.C., Zhang J., et al. Controlled release of acyclovir through bioengineered corneal implants with silica nanoparticle carriers. Open Tissue Eng. Regen. Med. J 2010, 3:10-17.
7. Bruining M.J., Pijpers A.P., Kingshott P., Koole L.H. Studies on new polymeric biomaterials with tunable hydrophilicity, and their possible utility in corneal repair surgery. Biomaterials 2002, 23:1213-1219.
8. Caporossi A., Baiocchi S., Mazzotta C., Traversi C., Caporossi T. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced crosslinking of corneal collagen: preliminary refractive results in an Italian study. J. Cataract Refract. Surg. 2006, 32:837-845.
9. Carrier P., Deschambeault A., Talbot M., Giasson C.J., Auger F.A., Guerin S.L., et al. Characterization of wound reepithelialization using a new human tissue-engineered corneal wound healing model. Invest. Ophthalmol. Vis. Sci. 2008, 49:1376-1385.
10. Chew H.F., Ayres B.D., Hammersmith K.M., Rapuano C.J., Laibson P.R., Myers J.S., et al. Boston keratoprosthesis outcomes and complications. Cornea 2009, 28:989-996.
11. Chirila T.V. An overview of the development of artificial corneas with porous skirts and the use of PHEMA for such an application. Biomaterials 2001, 22:3311-3317.
12. Chirila T.V., Barnard Z., Zainuddina, Harkin D.G., Schwab I.R., Hirst L.W. Bombyx mori silk fibroin membranes as potential substrata for epithelial constructs used in the management of ocular surface disorders. Tissue Eng. Part A 2008, 14:1203-1211.
13. Ciolino J.B., Hoare T.R., Iwata N.G., Behlau I., Dohlman C.H., Langer R., et al. A drug-eluting contact lens. Invest. Ophthalmol. Vis. Sci. 2009, 50:3346-3352.
14. Claesson M., Armitage W.J., Fagerholm P., Stenevi U. Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register. Br. J. Ophthalmol. 2002, 86:174-180.
15. Dohlman C.H., Grosskreutz C.L., Chen T.C., Pasquale L.R., Rubin P.A., Kim E.C., et al. Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery. J. Glaucoma 2010, 19:111-115.
16. Dravida S., Gaddipati S., Griffith M., Merrett K., Lakshmi S., Sangwan V.S., et al. A biomimetic scaffold for culturing limbal stem cells: promising alternative for clinical transplantation. J. Tissue Eng. Regen. Med. 2008, 2:263-271.
17. Du Y., Carlson E.C., Funderburgh M.L., Birk D.E., Pearlman E., Guo N., et al. Stem cell therapy restores transparency to defective murine corneas. Stem Cells 2009, 27:1635-1642.
18. Duan X., Sheardown H. Crosslinking of collagen with dendrimers. J. Biomed. Mater. Res. A 2005, 75:510-518.
19. Duan X., Sheardown H. Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: mechanical properties and corneal epithelial cell interactions. Biomaterials 2006, 27:4608-4617.
20. Duffy P., Wolf J., Collins G., DeVoe A.G., Streeten B., Cowen D. Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. N. Engl. J. Med. 1974, 290:692-693.
21. Durand M.L., Dohlman C.H. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea 2009, 28:896-901.
22. Fagerholm P., Lagali N.S., Merrett K., Jackson W.B., Munger R., Liu Y., et al. A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a Phase 1 clinical study. Sci. Transl. Med 2010, 2,. 46ra61.
23. Falcinelli G., Falsini B., Taloni M., Colliardo P., Falcinelli G. Modified osteo-odonto-keratoprosthesis for treatment of corneal blindness: long-term anatomical and functional outcomes in 181 cases. Arch. Ophthalmol. 2005, 123:1319-1329.
24. Funnell C.L., Ball J., Noble B.A. Comparative cohort study of the outcomes of deep lamellar keratoplasty and penetrating keratoplasty for keratoconus. Eye (Lond.) 2006, 20:527-532.
25. Gagnon N., Auger F., Germain L. Porcine corneal endothelial cell culture improvement: effect of initial seeding density and presence of a feeder layer. Invest. Ophthalmol. Vis. Sci. 2005, 46. E-Abstract 5006.
26. Gaudreault M., Carrier P., Larouche K., Leclerc S., Giasson M., Germain L., et al. Influence of sp1/sp3 expression on corneal epithelial cells proliferation and differentiation properties in reconstructed tissues. Invest. Ophthalmol. Vis. Sci. 2003, 44:1447-1457.
27. George A., Pitt W.G. Comparison of corneal epithelial cellular growth on synthetic cornea materials. Biomaterials 2002, 23:1369-1373.
28. Germain L., Auger F.A., Grandbois E., Guignard R., Giasson M., Boisjoly H., et al. Reconstructed human cornea produced in vitro by tissue engineering. Pathobiology 1999, 67:140-147.
29. Griffith M., Osborne R., Munger R., Xiong X., Doillon C.J., Laycock N.L., et al. Functional human corneal equivalents constructed from cell lines. Science 1999, 286:2169-2172.
30. Guo X., Hutcheon A.E., Melotti S.A., Zieske J.D., Trinkaus-Randall V., Ruberti J.W. Morphologic characterization of organized extracellular matrix deposition by ascorbic acid-stimulated human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 2007, 48:4050-4060.
31. Hafezi F., Mrochen M., Iseli H.P., Seiler T. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J. Cataract Refract. Surg. 2009, 35:621-624.
32. Han B., Schwab I.R., Madsen T.K., Isseroff R.R. A fibrin-based bioengineered ocular surface with human corneal epithelial stem cells. Cornea 2002, 21:505-510.
33. Hassan S.S., Wilhelmus K.R., Dahl P., Davis G.C., Roberts R.T., Ross K.W., et al. Infectious disease risk factors of corneal graft donors. Arch. Ophthalmol. 2008, 126:235-239.
34. Hicks C.R., Crawford G.J., Tan D.T., Snibson G.R., Sutton G.L., Gondhowiardjo T.D., et al. Outcomes of implantation of an artificial cornea, AlphaCor: effects of prior ocular herpes simplex infection. Cornea 2002, 21:685-690.
35. Hicks C.R., Crawford G.J., Lou X., Tan D.T., Snibson G.R., Sutton G., et al. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications. Eye (Lond.) 2003, 17:385-392.
36. Hicks C.R., Crawford G.J., Tan D.T., Snibson G.R., Sutton G.L., Downie N., et al. AlphaCor cases: comparative outcomes. Cornea 2003, 22:583-590.
37. Hicks C.R., Chirila T.V., Werner L., Crawford G.J., Apple D.J., Constable I.J. Deposits in artificial corneas: risk factors and prevention. Clin. Exp. Ophthalmol. 2004, 32:185-191.
38. Hicks C.R., Crawford G.J., Dart J.K., Grabner G., Holland E.J., Stulting R.D., et al. AlphaCor: clinical outcomes. Cornea 2006, 25:1034-1042.
39. Hoffman A.S. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 2002, 54:3-12.
40. Houff S.A., Burton R.C., Wilson R.W., Henson T.E., London W.T., Baer G.M., et al. Human- to-human transmission of rabies virus by corneal transplant. N. Engl. J. Med. 1979, 300:603-604.
41. Inatomi T., Nakamura T., Kojyo M., Koizumi N., Sotozono C., Kinoshita S. Ocular surface reconstruction with combination of cultivated autologous oral mucosal epithelial transplantation and penetrating keratoplasty. Am. J. Ophthalmol. 2006, 142:757-764.
42. Jacob J.T., Rochefort J.R., Bi J., Gebhardt B.M. Corneal epithelial cell growth over tethered-protein/peptide surface-modified hydrogels. J. Biomed. Mater. Res. B Appl. Biomater. 2005, 72:198-205.
43. Johnson G., Jenkins M., McLean K.M., Griesser H.J., Kwak J., Goodman M., et al. Peptoid-containing collagen mimetics with cell binding activity. J. Biomed. Mater. Res. 2000, 51:612-624.
44. Jonas J.B., Holbach L. Central corneal thickness and thickness of the lamina cribrosa in human eyes. Invest. Ophthalmol. Vis. Sci. 2005, 46:1275-1279.
45. Kaminski S.L., Biowski R., Lukas J.R., Koyuncu D., Grabner G. Corneal sensitivity 10 years after epikeratoplasty. J. Refract. Surg. 2002, 18:731-736.
46. Khan B., Dudenhoefer E.J., Dohlman C.H. Keratoprosthesis: an update. Curr. Opin. Ophthalmol. 2001, 12:282-287.
47. Khan B.F., Harissi-Dagher M., Pavan-Langston D., Aquavella J.V., Dohlman C.H. The Boston keratoprosthesis in herpetic keratitis. Arch. Ophthalmol. 2007, 125:745-749.
48. Kim M.K., Park I.S., Park H.D., Wee W.R., Lee J.H., Park K.D., et al. Effect of poly(ethylene glycol) graft polymerization of poly(methyl methacrylate) on cell adhesion. In vitro and in vivo study. J. Cataract Refract. Surg. 2001, 27:766-774.
49. Klenkler B.J., Griffith M., Becerril C., West-Mays J.A., Sheardown H. EGF-grafted PDMS surfaces in artificial cornea applications. Biomaterials 2005, 26:7286-7296.
50. Kobayashi H., Ikada Y. Corneal cell adhesion and proliferation on hydrogel sheets bound with cell-adhesive proteins. Curr. Eye Res. 1991, 10:899-908.
51. Koller T., Mrochen M., Seiler T. Complication and failure rates after corneal crosslinking. J. Cataract Refract. Surg. 2009, 35:1358-1362.
52. Lambiase A., Rama P., Aloe L., Bonini S. Management of neurotrophic keratopathy. Curr. Opin. Ophthalmol. 1999, 10:270-276.
53. Lee K.Y., Mooney D.J. Hydrogels for tissue engineering. Chem. Rev. 2001, 101:1869-1879.
54. Legeais J.M., Renard G. A second generation of artificial cornea (Biokpro II). Biomaterials 1998, 19:1517-1522.
55. Legeais J.M., Drubaix I., Briat B., Renard G., Pouliquen Y. 2nd generation bio-integrated keratoprosthesis. Implantation in animals. J. Fr. Ophtalmol. 1997, 20:42-48.
56. Li F., Carlsson D., Lohmann C., Suuronen E., Vascotto S., Kobuch K., et al. Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15346-15351.
57. Li F., Griffith M., Li Z., Tanodekaew S., Sheardown H., Hakim M., et al. Recruitment of multiple cell lines by collagen-synthetic copolymer matrices in corneal regeneration. Biomaterials 2005, 26:3093-3104.
58. Liu L., Sheardown H. Glucose permeable poly (dimethyl siloxane) poly (N-isopropyl acrylamide) interpenetrating networks as ophthalmic biomaterials. Biomaterials 2005, 26:233-244.
59. Liu W., Deng C., McLaughlin C.R., Fagerholm P., Lagali N.S., Heyne B., et al. Collagen-phosphorylcholine interpenetrating network hydrogels as corneal substitutes. Biomaterials 2009, 30:1551-1559.
60. McIntosh Ambrose W., Salahuddin A., So S., Ng S., Ponce Marquez S., Takezawa T., et al. Collagen Vitrigel membranes for the in vitro reconstruction of separate corneal epithelial, stromal, and endothelial cell layers. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 90:818-831.
61. McLaughlin C.R., Acosta M.C., Luna C., Liu W., Belmonte C., Griffith M., et al. Regeneration of functional nerves within full thickness collagen-phosphorylcholine corneal substitute implants in guinea pigs. Biomaterials 2010, 31:2770-2778.
62. Meek K.M., Leonard D.W. Ultrastructure of the corneal stroma: a comparative study. Biophys. J. 1993, 64:273-280.
63. Mehta J.S., Futter C.E., Sandeman S.R., Faragher R.G., Hing K.A., Tanner K.E., et al. Hydroxyapatite promotes superior keratocyte adhesion and proliferation in comparison with current keratoprosthesis skirt materials. Br. J. Ophthalmol. 2005, 89:1356-1362.
64. Merrett K., Griffith C.M., Deslandes Y., Pleizier G., Sheardown H. Adhesion of corneal epithelial cells to cell adhesion peptide modified pHEMA surfaces. J. Biomater. Sci. Polym. Ed. 2001, 12:647-671.
65. Merrett K., Griffith C.M., Deslandes Y., Pleizier G., Dube M.A., Sheardown H. Interactions of corneal cells with transforming growth factor beta 2- modified poly dimethyl siloxane surfaces. J. Biomed. Mater. Res. A 2003, 67:981-993.
66. Muraine M., Toubeau D., Menguy E., Brasseur G. Analysing the various obstacles to cornea postmortem procurement. Br. J. Ophthalmol. 2002, 86:864-868.
67. Myung D., Duhamel P.E., Cochran J.R., Noolandi J., Ta C.N., Frank C.W. Development of hydrogel-based keratoprostheses: a materials perspective. Biotechnol. Prog. 2008, 24:735-741.
68. Myung D., Farooqui N., Zheng L.L., Koh W., Gupta S., Bakri A., et al. Bioactive interpenetrating polymer network hydrogels that support corneal epithelial wound healing. J. Biomed. Mater. Res. A 2009, 90:70-81.
69. Nakamura T., Inatomi T., Sotozono C., Ang L.P., Koizumi N., Yokoi N., et al. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease. Ophthalmology 2006, 113:1765-1772.
70. Nishida T. Fundamentals of cornea and external disease. Cornea Vol.1 2005, 3-26. Elsevier, Mosby, PA. 2nd ed. J.H. Krachmer, M.J. Mannis, E.J. Holland (Eds.).
71. O'Day D.M. Diseases potentially transmitted through corneal transplantation. Ophthalmology 1989, 96:1133-1137. discussion 1137-1138.
72. Pierschbacher M.D., Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J. Biol. Chem. 1987, 262:17294-17298.
73. Ponce Marquez S., Martinez V.S., McIntosh Ambrose W., Wang J., Gantxegui N.G., Schein O., et al. Decellularization of bovine corneas for tissue engineering applications. Acta Biomater. 2009, 5:1839-1847.
74. Princz M.A., Griffith M., Sheardown H. Corneal tissue engineering versus synthetic artificial corneas. Biomaterials and Regenerative Medicine in Ophthalmology 2009, 134-149. CRC Press (Woodhead Publishing), Cambridge, UK. T.V. Chirila (Ed.).
75. Raiskup F., Hoyer A., Spoerl E. Permanent corneal haze after riboflavin-UVA-induced crosslinking in keratoconus. J. Refract. Surg. 2009, 25:S824-S828.
76. Rama P., Bonini S., Lambiase A., Golisano O., Paterna P., de Luca M., et al. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation 2001, 72:1478-1485.
77. Remeijer L., Maertzdorf J., Doornenbal P., Verjans G.M., Osterhaus A.D. Herpes simplex virus 1 transmission through corneal transplantation. Lancet 2001, 357:442.
78. Ren H., Wilson G. Apoptosis in the corneal epithelium. Invest. Ophthalmol. Vis. Sci. 1996, 37:1017-1025.
79. Rivier D., Paula J., Kim E., Dohlman C.H., Grosskreutz C. Glaucoma and keratoprostesis surgery: role of adjunctive cyclophotokoagulation. J. Glaucoma 2009, 18:321-324.
80. Sack R.A., Nunes I., Beaton A., Morris C. Host-defense mechanism of the ocular surfaces. Biosci. Rep. 2001, 21:463-480.
81. Sandeman S.R., Jeffery H., Howell C.A., Smith M., Mikhalovsky S.V., Lloyd A.W. The in vitro corneal biocompatibility of hydroxyapatite-coated carbon mesh. Biomaterials 2009, 30:3143-3149.
82. Seiler T., Hafezi F. Corneal crosslinking-induced stromal demarcation line. Cornea 2006, 25:1057-1059.
83. Spoerl E., Mrochen M., Sliney D., Trokel S., Seiler T. Safety of UVA-riboflavin crosslinking of the cornea. Cornea 2007, 26:385-389.
84. Strampelli B. Osteo-odontokeratoprosthesis. Ann. Ottalmol. Clin. Ocul. 1963, 89:1039-1044.
85. Sweeney D.F., Xie R.Z., Evans M.D., Vannas A., Tout S.D., Griesser H.J., et al. A comparison of biological coatings for the promotion of corneal epithelialization of synthetic surface in vivo. Invest. Ophthalmol. Vis. Sci. 2003, 44:3301-3309.
86. Trinkaus-Randall V. Cornea. Principles of Tissue Engineering 2000, 471-491. Academic Press, San Diego. R. Lanza, R. Langer, J. Vacanti (Eds.).
87. Viitala R., Franklin V., Green D., Liu C., Lloyd A., Tighe B. Towards a synthetic osteo-odonto-keratoprosthesis. Acta Biomater. 2009, 5:438-452.
88. Wallace C., Jacob J.T., Stoltz A., Bi J., Bundy K. Corneal epithelial adhesion strength to tethered-protein/peptide modified hydrogel surfaces. J. Biomed. Mater. Res. A 2005, 72:19-24.
89. Whitcher J.P., Srinivasan M., Upadhyay M.P. Corneal blindness: a global perspective. Bull. World Health Organ. 2001, 79:214-221.
90. Williams K.A., Esterman A.J., Bartlett C., Holland H., Hornsby N.B., Coster D.J. How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation 2006, 81:896-901.
91. Wollensak G., Spoerl E., Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am. J. Ophthalmol. 2003, 135:620-627.